Boscaro, Marco

A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients

Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology

Hormonal Regulation and HypertensionAdrenal and Paraganglionic Tumors

Cited by 1,467

Diagnosis and complications of Cushing’s syndrome: a consensus statement

Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 1,362

Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement

Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 853

Prevalence and natural history of adrenal incidentalomas

Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 642

Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism

Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 324

High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines

Mancini, T., Kola, B., Mantero, F., Boscaro, M., & Arnaldi, G. (2004) · Clinical Endocrinology

Pituitary Gland Disorders and TreatmentsHormonal Regulation and Hypertension

Cited by 278

Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study

Deutschbein, T., Reimondo, G., Di Dalmazi, G., Bancos, I., Patrova, J., Vassiliadi, D. A., Nekić, A. B., Debono, M., Lardo, P., Ceccato, F., et al. (2022) · The Lancet Diabetes & Endocrinology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 205

Ketoconazole treatment in Cushing’s syndrome: experience in 34 patients

Sonino, N., Boscaro, M., Paoletta, A., Mantero, F., & Zillotto, D. (1991) · Clinical Endocrinology

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 201

Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study

Giacchetti, G., Ronconi, V., Turchi, F., Agostinelli, L., Mantero, F., Rilli, S., & Boscaro, M. (2007) · Journal of Hypertension

Hormonal Regulation and HypertensionPotassium and Related Disorders

Cited by 196

Development of overt Cushing’s syndrome in patients with adrenal incidentaloma

Barzon, L., Fallo, F., Sonino, N., & Boscaro, M. (2002) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsPituitary Gland Disorders and Treatments

Cited by 162

Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management

Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 140

Cardiovascular risk in Cushing’s syndrome

Arnaldi, G., Mancini, T., Polenta, B., & Boscaro, M. (2004) · Pituitary

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 103

Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors

Barzon, L., Chilosi, M., Fallo, F., Martignoni, G., Montagna, L., Palu, G., & Boscaro, M. (2001) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsChromatin Remodeling and Cancer

Cited by 94

P450c17 deficiency: clinical and molecular characterization of six patients

Rosa, S., Duff, C., Meyer, M., Lang-Muritano, M., Balercia, G., Boscaro, M., Kemal Topaloglu, A., Mioni, R., Fallo, F., Zuliani, L., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism

Sexual Differentiation and DisordersAdrenal Hormones and Disorders

Cited by 71

Cushing’s Syndrome: Screening and Diagnosis

Ceccato, F., & Boscaro, M. (2016) · High Blood Pressure & Cardiovascular Prevention

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 70

Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome

Trementino, L., Appolloni, G., Concettoni, C., Cardinaletti, M., Boscaro, M., & Arnaldi, G. (2012) · European Journal of Endocrinology

Adrenal Hormones and DisordersPituitary Gland Disorders and Treatments

Cited by 53

First-line screening tests for Cushing’s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS

Ceccato, F., Antonelli, G., Frigo, A. C., Regazzo, D., Plebani, M., Boscaro, M., & Scaroni, C. (2017) · Journal of Endocrinological Investigation

Adrenal and Paraganglionic TumorsPituitary Gland Disorders and Treatments

Cited by 44

Response of pituitary-adrenal axis to corticotrophin releasing hormone in patients with Cushing’s disease before and after ketoconazole treatment

BOSCARO, M., SONINO, N., RAMPAZZO, A., & MANTERO, F. (1987) · Clinical Endocrinology

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 43

Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Ceccato, F., Barbot, M., Albiger, N., Zilio, M., De Toni, P., Luisetto, G., Zaninotto, M., Greggio, N. A., Boscaro, M., Scaroni, C., et al. (2016) · European Journal of Endocrinology

Sexual Differentiation and DisordersAdrenal Hormones and Disorders

Cited by 42

Metabolic syndrome in primary aldosteronism and essential hypertension: Relationship to adiponectin gene variants

Ronconi, V., Turchi, F., Rilli, S., Di Mattia, D., Agostinelli, L., Boscaro, M., & Giacchetti, G. (2010) · Nutrition, Metabolism and Cardiovascular Diseases

Hormonal Regulation and HypertensionAdipokines, Inflammation, and Metabolic Diseases

Cited by 41

Effect of the serotonin antagonists ritanserin and ketanserin in Cushing’s disease

Sonino, N., Fava, G. A., Fallo, F., Franceschetto, A., Belluardo, P., & Boscaro, M. (2000) · Pituitary

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 41

Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma

Ceccato, F., Barbot, M., Albiger, N., Antonelli, G., Zilio, M., Todeschini, M., Regazzo, D., Plebani, M., Lacognata, C., Iacobone, M., et al. (2018) · Endocrine

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 38

Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI

Sabbadin, C., Andrisani, A., Zermiani, M., Donà, G., Bordin, L., Ragazzi, E., Boscaro, M., Ambrosini, G., & Armanini, D. (2016) · Journal of Endocrinological Investigation

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 33

Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation

Guerrieri, M., Campagnacci, R., Patrizi, A., Romiti, C., Arnaldi, G., & Boscaro, M. (2010) · Surgical Endoscopy

Adrenal and Paraganglionic TumorsPituitary Gland Disorders and Treatments

Cited by 26